Premium
Granulocyte—colony‐stimulating factor (Filgrastim) may overcome imatinib‐induced neutropenia in patients with chronic‐phase myelogenous leukemia
Author(s) -
Jørgensen Heather G.,
Copland Mhairi,
Holyoake Tessa L.
Publication year - 2004
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.20742
Subject(s) - granulocyte colony stimulating factor , chronic myelogenous leukemia , medicine , neutropenia , imatinib , filgrastim , progenitor cell , haematopoiesis , immunology , cd34 , leukemia , granulocyte colony stimulating factor receptor , cancer research , myeloid leukemia , stem cell , biology , chemotherapy , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom